Clinical Trial: A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized, Double-Blind, Vehicle-Controlled, PArallel Group Study of the Safety and Effectiveness of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Tru

Brief Summary: This is a randomized, double-blind, vehicle-controlled, parallel group study.

Detailed Summary: This is a randomized, double-blind, vehicle-controlled, parallel group study. During this study, the investigator will identify 4 eligible SK Target Lesions on each subject on the trunk, extremities and face.
Sponsor: Aclaris Therapeutics, Inc.

Current Primary Outcome: Lesion Clearance Scale [ Time Frame: Study day 106 ]

Original Primary Outcome: Lesion Clearance [ Time Frame: Study day 106 ]

Current Secondary Outcome: Percent of lesions cleared Scale [ Time Frame: Study day 106 ]

Original Secondary Outcome: Percent of lesions cleared [ Time Frame: Study day 106 ]

Information By: Aclaris Therapeutics, Inc.

Dates:
Date Received: January 26, 2016
Date Started: January 2016
Date Completion:
Last Updated: December 1, 2016
Last Verified: January 2016